Provention Bio Inc.

NASDAQ: PRVB · Real-Time Price · USD
24.98
0.00 (0.00%)
At close: Apr 26, 2023, 10:00 PM

Provention Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-113.56M -106.12M -104.5M -103.96M -114.43M -121.18M -125.46M -118.44M
Depreciation & Amortization
1.23M 554K 506K 451K 387K 250K 154K 73K
Stock-Based Compensation
19.03M 12.4M 12.23M 12.3M 11.84M 17.25M 16.83M 14.84M
Other Working Capital
17.31M 1.66M -2.73M -2.12M 10.34M 10.02M 15.87M 14.63M
Other Non-Cash Items
-36K 452K 437K 450K 501K 576K 584K 493K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
17.94M 1.82M -942K -3.17M 6.32M 6.54M 11.91M 19.37M
Operating Cash Flow
-75.41M -90.89M -92.27M -93.93M -95.39M -96.56M -95.97M -83.66M
Capital Expenditures
-795K -464K -262K -711K -961K -1.68M -1.68M -1.01M
Cash Acquisitions
n/a 31.1M 31.1M 31.1M 31.1M -25.53M -25.53M -25.53M
Purchase of Investments
-103.08M -88.14M -38.96M -42.89M -55.28M -20.37M -35.99M -32.06M
Sales Maturities Of Investments
30.75M 14.06M 23.81M 29.93M 25.15M 36.84M 36.94M 43.82M
Other Investing Acitivies
-15M -31.1M -31.1M -31.1M -31.1M 25.53M 25.17M 25.17M
Investing Cash Flow
-88.13M -74.55M -15.41M -13.67M -31.1M 14.79M -1.09M 10.4M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
129.38M 230.81M 116.11M 104.48M 204.71M 102.67M 102.95M 216.47M
Financial Cash Flow
129.38M 128.48M 13.79M 2.15M 102.38M 102.67M 102.95M 216.47M
Net Cash Flow
-34.15M -36.96M -93.9M -105.45M -24.1M 20.9M 5.89M 143.22M
Free Cash Flow
-76.2M -91.35M -92.53M -94.64M -96.35M -98.24M -97.66M -84.66M